Stock Price
35.49
Daily Change
-0.85 -2.34%
Monthly
-6.38%
Yearly
-41.13%
Q2 Forecast
34.78

CONMED reported $13.83M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
3M USD 653M 76M Mar/2026
Abbott USD 1.08B 699M Mar/2026
Accuray USD 2.54M 6.49M Dec/2024
AtriCure USD 108K 1.65M Mar/2026
Avanos Medical USD 5.1M 6.4M Mar/2026
Baxter International USD -15M 1.11B Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Boston Scientific USD 1.34B 669M Mar/2026
CONMED USD 13.83M 2.91M Mar/2026
Cooper Companies USD 130.8M 46.2M Dec/2025
Dexcom USD 199.5M 67.8M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Globus Medical USD 140.59M 21.63M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 91.1M 10.5M Mar/2026
Integra LifeSciences USD -4.62M 2.91M Mar/2026
Intuitive Surgical USD 821.5M 26.7M Mar/2026
J&J USD 5.24B 119M Mar/2026
Masimo USD 57.1M 11.2M Mar/2026
Medtronic USD 1.14B 231M Dec/2025
Merit Medical Systems USD 41M 2.99M Mar/2026
Olympus JPY 24.82B 10.65B Mar/2026
Orthofix International USD -2.22M 20.57M Dec/2025
ResMed USD 398.73M 6.14M Mar/2026
Smith & Nephew USD 293M 79M Dec/2025
Steris USD 220.3M 27.4M Mar/2026
Stryker USD 745M 104M Mar/2026
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -8.15M 706.18M Mar/2026
Zimmer Biomet Holdings USD 238.1M 98.8M Mar/2026